Enhancing Treatment Decision-Making: Pilot Study of a Treatment Decision Aid in Stage IV Non-Small Cell Lung Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6604395
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

P1.13-03 Ensartinib Treatment Beyond Disease Progression in Stage IV ALK+ Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.11-10 Lung Cancer Screening Shared Decision Making: Decision-Aid for the Patient

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Exploring Cancer Treatment Decision-Making by Patients: A Descriptive Study

Current Oncology
Oncology
2010English

Neo-Adjuvant Chemo/Immunotherapy in the Treatment of Stage III (N2) Non-Small Cell Lung Cancer: A Phase I/Ii Pilot Study

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2011English

Social Factors, Treatment, and Survival in Early-Stage Non-Small Cell Lung Cancer.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1998English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

P1.15-28 Real World Treatment Patterns and Survival of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Applicability of a Prognostic CT-based Radiomic Signature Model Trained on Stage I-Iii Non-Small Cell Lung Cancer in Stage IV Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy